11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress

Frontiers in Neuroendocrinology

Volumn 32, Issue 3, 2011, Pages 265-286

  Wyrwoll, Caitlin S ^a   Holmes, Megan C ^a   Seckl, Jonathan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

11 Hydroxysteroid dehydrogenase; Ageing; Anxiety; Developmental programming; Glucocorticoids; HPA axis; Mineralocorticoids

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; 11BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR; ADAMANTYLTRIAZOLE DERIVATIVE; ARYLSULFONAMIDOTHIAZOLE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBENOXOLONE; CCAAT ENHANCER BINDING PROTEIN BETA; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCYRRHIZIC ACID; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; OCTYLTRIAZOLE DERIVATIVE; OXIDOREDUCTASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYLTRIAZOLE DERIVATIVE; PLACEBO; PROTEIN C FOS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIAZOLE DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AFFECT; AGING; ANXIETY; APPARENT MINERALOCORTICOID EXCESS SYNDROME; BRAIN DEVELOPMENT; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CELL METABOLISM; CIRCADIAN RHYTHM; COGNITIVE DEFECT; DRUG EFFECT; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FOOD INTAKE; HIPPOCAMPUS; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; METABOLIC DISORDER; NEOCORTEX; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DENSITY; REVIEW; SIGNAL TRANSDUCTION; STEROID BLOOD LEVEL; TISSUE DISTRIBUTION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; AGING; ANIMALS; BRAIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; HUMANS; ISOENZYMES; SIGNAL TRANSDUCTION;

EID: 79960560115     PISSN: 00913022     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.yfrne.2010.12.001     Document Type: Review

References (324)

1. Agarwal A.K., Monder C., Eckstein B., White P.C. Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J. Biol. Chem. 1989, 264:18939-18943.
2. Agarwal A.K., Mune T., Monder C., White P.C. NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 1994, 269:25959-25962.
3. Agarwal A.K., Tusie-Luna M.T., Monder C., White P.C. Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol. Endocrinol. 1990, 4:1827-1832.
4. Alberts P., Engblom L., Edling N., Forsgren M., Klingstrom G., Larsson C., Ronquist-Nii Y., Ohman B., Abrahmsen L. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 2002, 45:1528-1532.
5. Alberts P., Nilsson C., Selen G., Engblom L.O., Edling N.H., Norling S., Klingstrom G., Larsson C., Forsgren M., Ashkzari M., Nilsson C.E., Fiedler M., Bergqvist E., Ohman B., Bjorkstrand E., Abrahmsen L.B. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 2003, 144:4755-4762.
6. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell Endocrinol. 1994, 105:R11-R17.
7. Alfaidy N., Gupta S., DeMarco C., Caniggia I., Challis J.R. Oxygen regulation of placental 11 beta-hydroxysteroid dehydrogenase 2: physiological and pathological implications. J. Clin. Endocrinol. Metab. 2002, 87:4797-4805.
8. Alikhani-Koopaei R., Fouladkou F., Frey F.J., Frey B.M. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J. Clin. Invest. 2004, 114:1146-1157.
9. Amelung D., Hubener H.J., Roka L., Meyerheim G. Conversion of cortisone to compound F. J. Clin. Endocrinol. Metab. 1953, 13:1125-1126.
10. Andrews R.C., Rooyackers O., Walker B.R. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J. Clin. Endocrinol. Metab. 2003, 88:285-291.
11. Arriza J.L., Simerly R.B., Swanson L.W., Evans R.M. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1988, 1:887-900.
12. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 2004, 61:661-666.
13. Aster S.D., Graham D.W., Kharbanda D., Patel G., Ponpipom M., Santorelli G.M., Szymonifka M.J., Mundt S.S., Shah K., Springer M.S., Thieringer R., Hermanowski-Vosatka A., Wright S.D., Xiao J., Zokian H., Balkovec J.M. Bis-aryl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. Bioorg. Med. Chem. Lett. 2008, 18:2799-2804.
14. Atanasov A.G., Nashev L.G., Gelman L., Legeza B., Sack R., Portmann R., Odermatt A. Direct protein-protein interaction of 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen. Biochim. Biophys. Acta 2008, 1783:1536-1543.
15. Baker M.E. Licorice and enzymes other than 11 beta-hydroxysteroid dehydrogenase: an evolutionary perspective. Steroids 1994, 59:136-141.
16. Barf T., Vallgarda J., Emond R., Haggstrom C., Kurz G., Nygren A., Larwood V., Mosialou E., Axelsson K., Olsson R., Engblom L., Edling N., Ronquist-Nii Y., Ohman B., Alberts P., Abrahmsen L. Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. J. Med. Chem. 2002, 45:3813-3815.
17. Basu R., Singh R.J., Basu A., Chittilapilly E.G., Johnson C.M., Toffolo G., Cobelli C., Rizza R.A. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway. Diabetes 2004, 53:2051-2059.
18. Bauer B., Hartz A.M., Fricker G., Miller D.S. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol. 2004, 66:413-419.
19. Beitins I.Z., Bayard F., Ances I.G., Kowarski A., Migeon C.J. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr. Res. 1973, 7:509-519.
20. Benediktsson R., Calder A.A., Edwards C.R., Seckl J.R. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin. Endocrinol. (Oxf) 1997, 46:161-166.
21. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., Edwards C.R. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993, 341:339-341.
22. Berger J., Tanen M., Elbrecht A., Hermanowski-Vosatka A., Moller D.E., Wright S.D., Thieringer R. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J. Biol. Chem. 2001, 276:12629-12635.
23. Bohn M.C. Granule cell genesis in the hippocampus of rats treated neonatally with hydrocortisone. Neuroscience 1980, 5:2003-2012.
24. Boyle M.P., Kolber B.J., Vogt S.K., Wozniak D.F., Muglia L.J. Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. J. Neurosci. 2006, 26:1971-1978.
25. Bremner J.D., Randall P., Scott T.M., Bronen R.A., Seibyl J.P., Southwick S.M., Delaney R.C., McCarthy G., Charney D.S., Innis R.B. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder.[comment]. Am. J. Psychiat. 1995, 152:973-981.
26. Breuner C.W., Orchinik M. Plasma binding proteins as mediators of corticosteroid action in vertebrates. J. Endocrinol. 2002, 175:99-112.
27. Brown R.W., Chapman K.E., Edwards C.R., Seckl J.R. Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology 1993, 132:2614-2621.
28. Brown R.W., Diaz R., Robson A.C., Kotelevtsev Y.V., Mullins J.J., Kaufman M.H., Seckl J.R. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 1996, 137:794-797.
29. Brown R.W., Kotolevtsev Y., Leckie C., Lindsay R.S., Lyons V., Murad P., Mullins J.J., Chapman K.E., Edwards C.R.W., Seckl J.R. Isolation and cloning of human placental 11ß-hydroxysteroid dehydrogenase-2 cDNA. Biochem. J. 1996, 313:1007-1017.
30. Bruley C., Lyons V., Worsley A.G., Wilde M.D., Darlington G.D., Morton N.M., Seckl J.R., Chapman K.E. A novel promoter for the 11beta-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPalpha independent. Endocrinology 2006, 147:2879-2885.
31. Bujalska I.J., Kumar S., Hewison M., Stewart P.M. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 1999, 140:3188-3196.
32. Buren J., Bergstrom S.A., Loh E., Soderstrom I., Olsson T., Mattsson C. Hippocampal 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese Zucker rat. Endocrinology 2007, 148:2716-2722.
33. Burton A.F., Turnell R.W. 11-dehydrocorticosteroids in tissues of mice. Can. J. Biochem. 1968, 46:497-502.
34. Burton P.J., Smith R.E., Krozowski Z.S., Waddell B.J. Zonal distribution of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 messenger ribonucleic acid expression in the rat placenta and decidua during late pregnancy. Biol. Reprod. 1996, 55:1023-1028.
35. Burton P.J., Waddell B.J. 11 β-Hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure. J. Endocrinol. 1994, 143:505-513.
36. Campbell L.E., Yu M., Yang K. Ovine 11 beta-hydroxysteroid dehydrogenase type 2 gene predicts a protein distinct from that deduced by the cloned kidney cDNA at the C-terminus. Mol. Cell. Endocrinol. 1996, 119:113-118.
37. Carroll B.J., Curtis G.C., Mendels J. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch. Gen. Psychiat. 1976, 33:1051-1058.
38. Carter R.N., Paterson J.M., Tworowska U., Stenvers D.J., Mullins J.J., Seckl J.R., Holmes M.C. Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent. J. Neuroendocrinol. 2009, 21:879-887.
39. Christy C., Hadoke P.W., Paterson J.M., Mullins J.J., Seckl J.R., Walker B.R. 11beta-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids. Hypertension 2003, 42:580-587.
40. Cohen S.I. Cushing's syndrome: a psychiatric study of 29 patients. Brit. J. Psychiat. 1980, 136:120-124.
41. Coirini H., Magarinos A.M., De Nicola A.F., Rainbow T.C., McEwen B.S. Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro. Brain Res. 1985, 361:212-216.
42. Cole T.J. Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 1995, 136:4693-4696.
43. Constancia M., Angiolini E., Sandovici I., Smith P., Smith R., Kelsey G., Dean W., Ferguson-Smith A., Sibley C.P., Reik W., Fowden A. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Proc. Natl. Acad. Sci. USA 2005, 102:19219-19224.
44. Cooper M.S., Rabbitt E.H., Goddard P.E., Bartlett W.A., Hewison M., Stewart P.M. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J. Bone Miner. Res. 2002, 17:979-986.
45. Coryell W., Young E., Carroll B. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiat. Res. 2006, 142:99-104.
46. Cratty M.S., Ward H.E., Johnson E.A., Azzaro A.J., Birkle D.L. Prenatal stress increases corticotropin-releasing factor (CRF) content and release in rat amygdala minces. Brain Res. 1995, 675:297-302.
47. Dalle M., Giry J., Gay M., Delost P. Perinatal changes in plasma and adrenal corticosterone and aldosterone concentrations in the mouse. J. Endocrinol. 1978, 76:303-309.
48. Dave-Sharma S., Wilson R.C., Harbison M.D., Newfield R., Azar M.R., Krozowski Z.S., Funder J.W., Shackleton C.H., Bradlow H.L., Wei J.Q., Hertecant J., Moran A., Neiberger R.E., Balfe J.W., Fattah A., Daneman D., Akkurt H.I., De Santis C., New M.I. Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 1998, 83:2244-2254.
49. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475.
50. de Kloet E.R., Karst H., Joels M. Corticosteroid hormones in the central stress response: quick-and-slow. Front Neuroendocrinol. 2008, 29:268-272.
51. de Kloet E.R., Reul J.M. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987, 12:83-105.
52. de Kloet E.R., Rosenfeld P., Van Eekelen J.A., Sutanto W., Levine S. Stress, glucocorticoids and development. Prog. Brain Res. 1988, 73:101-120.
53. de Kloet E.R., Van Acker S.A., Sibug R.M., Oitzl M.S., Meijer O.C., Rahmouni K., de Jong W. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int. 2000, 57:1329-1336.
54. de Quervain D.J., Poirier R., Wollmer M.A., Grimaldi L.M., Tsolaki M., Streffer J.R., Hock C., Nitsch R.M., Mohajeri M.H., Papassotiropoulos A. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum. Mol. Genet. 2004, 13:47-52.
55. de Vries A., Holmes M., Heijnis A., Seier J., van Heerden J., Louw J., Wolfe-Coote S., Meaney M., Levitt N., Seckl J. Prenatal dexamethasone exposure induces changes in offspring cardio-metabolic and hypothalamic-pituitary-adrenal axis function without alteration of birth weight in a non-human primate, the African vervet, Chlorocebus aethiops. J. Clin. Invest. 2007, 117:1058-1067.
56. Deary I.J., Hayward C., Permana P.A., Nair S., Whalley L.J., Starr J.M., Chapman K.E., Walker B.R., Seckl J.R. Polymorphisms in the gene encoding 11B-hydroxysteroid dehydrogenase type 1 (HSD11B1) and lifetime cognitive change. Neurosci. Lett. 2006, 393:74-77.
57. Densmore V.S., Morton N.M., Mullins J.J., Seckl J.R. 11 beta-hydroxysteroid dehydrogenase type 1 induction in the arcuate nucleus by high-fat feeding: a novel constraint to hyperphagia?. Endocrinology 2006, 147:4486-4495.
58. Diaz R., Brown R.W., Seckl J.R. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. J. Neurosci. 1998, 18:2570-2580.
59. Diestel A., Aktas O., Hackel D., Hake I., Meier S., Raine C.S., Nitsch R., Zipp F., Ullrich O. Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J. Exp. Med. 2003, 198:1729-1740.
60. Dodic M., Hantzis V., Duncan J., Rees S., Koukoulas I., Johnson K., Wintour E.M., Moritz K. Programming effects of short prenatal exposure to cortisol. Faseb J. 2002, 16:1017-1026.
61. Dodic M., May C.N., Wintour E.M., Coghlan J.P. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin. Sci. 1998, 94:149-155.
62. Dodic M., Moritz K., Koukoulas I., Wintour E.M. Programmed hypertension: kidney, brain or both?. Trends Endocrinol. Metab. 2002, 13:403-408.
63. Dodic M., Peers A., Coghlan J., May C., Lumbers E., Yu Z., Wintour E. Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin. Sci. 1999, 97:103-109.
64. Drake A.J., Walker B.R., Seckl J.R. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R34-R38.
65. Draper N., Stewart P.M. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J. Endocrinol. 2005, 186:251-271.
66. Dzyakanchuk A.A., Balazs Z., Nashev L.G., Amrein K.E., Odermatt A. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose. Mol. Cell Endocrinol. 2009, 301:137-141.
67. Edwards C.R., Benediktsson R., Lindsay R.S., Seckl J.R. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?. Lancet 1993, 341:355-357.
68. Edwards C.R., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., de Kloet E.R., Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988, 2:986-989.
69. Engeli S., Bohnke J., Feldpausch M., Gorzelniak K., Heintze U., Janke J., Luft F.C., Sharma A.M. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes. Res. 2004, 12:9-17.
70. Funder J.W. Mineralocorticoid receptors in the central nervous system. J. Steroid Biochem. Mol. Biol. 1996, 56:179-183.
71. Funder J.W. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu. Rev. Med. 1997, 48:231-240.
72. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme not receptor mediated. Science 1988, 242:583-585.
73. Fuxe K., Wikstrom A.C., Okret S., Agnati L.F., Harfstrand A., Yu Z.Y., Granholm L., Zoli M., Vale W., Gustafsson J.A. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 1985, 117:1803-1812.
74. Gatford K.L., Wintour E.M., de Blasio M.J., Owens J.A., Dodic M. Differential timing for programming of glucose homoeostasis, sensitivity to insulin and blood pressure by in utero exposure to dexamethasone in sheep. Clin. Sci. 2000, 98:553-560.
75. Geerling J.C., Engeland W.C., Kawata M., Loewy A.D. Aldosterone target neurons in the nucleus tractus solitarius drive sodium appetite. J. Neurosci. 2006, 26:411-417.
76. Geerling J.C., Kawata M., Loewy A.D. Aldosterone-sensitive neurons in the rat central nervous system. J. Comp. Neurol. 2006, 494:515-527.
77. Geerling J.C., Loewy A.D. Aldosterone-sensitive neurons in the nucleus of the solitary tract: bidirectional connections with the central nucleus of the amygdala. J. Comp. Neurol. 2006, 497:646-657.
78. Geerling J.C., Loewy A.D. Aldosterone-sensitive neurons in the nucleus of the solitary tract: efferent projections. J. Comp. Neurol. 2006, 497:223-250.
79. Geerling J.C., Loewy A.D. Aldosterone in the brain. Am. J. Physiol. Renal Physiol. 2009, 297:F559-F576.
80. Gereben B., Zeold A., Dentice M., Salvatore D., Bianco A.C. Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell Mol. Life Sci. 2008, 65:570-590.
81. Giguere V., Yang N., Segui P., Evans R.M. Identification of a new class of steroid hormone receptors. Nature 1988, 331:91-94.
82. Glock G.E., McLean P. Levels of oxidized and reduced diphosphopyridine nucleotide and triphosphopyridine nucleotide in animal tissues. Biochem. J. 1955, 61:388-390.
83. Gomez-Sanchez E.P., Romero D.G., de Rodriguez A.F., Warden M.P., Krozowski Z., Gomez-Sanchez C.E. Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat. Endocrinology 2008, 149:525-533.
84. Gottfried-Blackmore A., Sierra A., McEwen B.S., Ge R., Bulloch K. Microglia express functional 11 beta-hydroxysteroid dehydrogenase type 1. Glia 2010, 58:1257-1266.
85. Gould E., Woolley C.S., McEwen B.S. Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J. Comp. Neurol. 1991, 313:479-485.
86. Grosser B.I. 11-beta-Hydroxysteroid metabolism by mouse brain and glioma 261. J. Neurochem. 1966, 13:475-478.
87. Grosser B.I., Axelrod L.R. Conversion of cortisol to cortisol acetate cortisone acetate and cortisone by the developing primate brain. Steroids 1968, 11:827-836.
88. Guan X., Wilson S., Schlender K.K., Ruch R.J. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18 beta-glycyrrhetinic acid. Mol. Carcinogen. 1996, 16:157-164.
89. Guzman C., Cabrera R., Cardenas M., Larrea F., Nathanielsz P.W., Zambrano E. Protein restriction during fetal and neonatal development in the rat alters reproductive function and accelerates reproductive ageing in female progeny. J. Physiol. 2006, 572:97-108.
90. Hadoke P.W., Macdonald L., Logie J.J., Small G.R., Dover A.R., Walker B.R. Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function. Cell Mol. Life Sci. 2006, 63:565-578.
91. Hammami M.M., Siiteri P.K. Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J. Clin. Endocrinol. Metab. 1991, 73:326-334.
92. Hardy D.B., Pereria L.E., Yang K. Prostaglandins and leukotriene B4 are potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 2 activity in human choriocarcinoma JEG-3 cells. Biol. Reprod. 1999, 61:40-45.
93. Hardy D.B., Yang K. The expression of 11 beta-hydroxysteroid dehydrogenase type 2 is induced during trophoblast differentiation: effects of hypoxia. J. Clin. Endocrinol. Metab. 2002, 87:3696-3701.
94. Harris H.J., Kotelevtsev Y., Mullins J.J., Seckl J.R., Holmes M.C. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice. Endocrinology 2001, 142:114-120.
95. Heine V.M., Rowitch D.H. Hedgehog signaling has a protective effect in glucocorticoid-induced mouse neonatal brain injury through an 11betaHSD2-dependent mechanism. J. Clin. Invest. 2009, 119:267-277.
96. Hench P.S., Kendall E.C., et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin. Proc. 1949, 24:181-197.
97. Hermanowski-Vosatka A., Balkovec J.M., Cheng K., Chen H.Y., Hernandez M., Koo G.C., Le Grand C.B., Li Z., Metzger J.M., Mundt S.S., Noonan H., Nunes C.N., Olson S.H., Pikounis B., Ren N., Robertson N., Schaeffer J.M., Shah K., Springer M.S., Strack A.M., Strowski M., Wu K., Wu T., Xiao J., Zhang B.B., Wright S.D., Thieringer R. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J. Exp. Med. 2005, 202:517-527.
98. Hermanowski-Vosatka A., Gerhold D., Mundt S.S., Loving V.A., Lu M., Chen Y., Elbrecht A., Wu M., Doebber T., Kelly L., Milot D., Guo Q., Wang P.R., Ippolito M., Chao Y.S., Wright S.D., Thieringer R. PPAR alpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver. Biochem. Biophys. Res. Commun. 2000, 279:330-336.
99. Heuer H., Visser T.J. Minireview: pathophysiological importance of thyroid hormone transporters. Endocrinology 2009, 150:1078-1083.
100. Hewitt D.P., Mark P.J., Waddell B.J. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology 2006, 147:5568-5574.
101. Holmes M.C., Abrahamsen C.T., French K.L., Paterson J.M., Mullins J.J., Seckl J.R. The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J. Neurosci. 2006, 26:3840-3844.
102. Holmes M.C., Carter R.N., Noble J., Chitnis S., Dutia A., Paterson J.M., Mullins J.J., Seckl J.R., Yau J.L. 11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments. J. Neurosci. 2010, 30:6916-6920.
103. Holmes M.C., French K.L., Seckl J.R. Dysregulation of diurnal rhythms of serotonin 5-HT 2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids. J. Neurosci. 1997, 17:4056-4065.
104. Holmes M.C., Sangra M., French K.L., Whittle I.R., Paterson J., Mullins J.J., Seckl J.R. 11beta-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids. Neuroscience 2006, 137:865-873.
105. Holmes M.C., Seckl J.R. The role of 11beta-hydroxysteroid dehydrogenases in the brain. Mol. Cell Endocrinol. 2006, 248:9-14.
106. Hsu D., Chen F., Takahashi L., Kalin N. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res. 1998, 788:305-310.
107. Huang W.L., Beazley L.D., Quinlivan J.A., Evans S.F., Newnham J.P., Dunlop S.A. Effect of corticosteroids on brain growth in fetal sheep. Obstetr. Gynecol. 1999, 94:213-218.
108. Huang W.L., Harper C.G., Evans S.F., Newnham J.P., Dunlop S.A. Repeated prenatal corticosteroid administration delays astrocyte and capillary tight junction maturation in fetal sheep. Int. J. Dev. Neurosci. 2001, 19:487-493.
109. Hughes K.A., Webster S.P., Walker B.R. 11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity. Exp. Opin. Invest. Drugs 2008, 17:481-496.
110. Hundertmark S., Dill A., Ebert A., Zimmermann B., Kotelevtsev Y.V., Mullins J.J., Seckl J.R. Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice. Horm. Metab. Res. 2002, 34:545-549.
111. Hundertmark S., Ragosch V., Schein B., Buhler H., Lorenz U., Fromm M., Weitzel H.K. Gestational age dependence of 11 beta-hydroxysteroid dehydrogenase and its relationship to the enzymes of phosphatidylcholine synthesis in lung and liver of fetal rat. Biochim. Biophys. Acta 1994, 1210:348-354.
112. Isbrucker R.A., Burdock G.A. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul. Toxicol. Pharmacol. 2006, 46:167-192.
113. Jamieson P.M., Chapman K.E., Edwards C.R., Seckl J.R. 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 1995, 136:4754-4761.
114. Jamieson P.M., Chapman K.E., Seckl J.R. Tissue- and temporal-specific regulation of 11beta-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo. J. Steroid Biochem. Mol. Biol. 1999, 68:245-250.
115. Jamieson P.M., Fuchs E., Flugge G., Seckl J.R. Attenuation of Hippocampal 11beta-hydroxysteroid Dehydrogenase Type 1 by Chronic Psychosocial Stress in the Tree Shrew. Stress 1997, 2:123-132.
116. Jellinck P.H., Dhabhar F.S., Sakai R.R., McEwen B.S. Long-term corticosteroid treatment but not chronic stress affects 11beta-hydroxysteroid dehydrogenase type I activity in rat brain and peripheral tissues. J. Steroid Biochem. Mol. Biol. 1997, 60:319-323.
117. Jensen E.C., Gallaher B.W., Breier B.H., Harding J.E. The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep. J. Endocrinol. 2002, 174:27-36.
118. Joels M., Baram T.Z. The neuro-symphony of stress. Nat. Rev. Neurosci. 2009, 10:459-466.
119. Joels M., de Kloet E.R. Effect of corticosteroid hormones on electrical activity in rat hippocampus. J. Steroid Biochem. Mol. Biol. 1991, 40:83-86.
120. Joels M., Krugers H.J., Lucassen P.J., Karst H. Corticosteroid effects on cellular physiology of limbic cells. Brain Res. 2009, 1293:91-100.
121. Johnstone H.A., Wigger A., Douglas A.J., Neumann I.D., Landgraf R., Seckl J.R., Russell J.A. Attenuation of hypothalamic-pituitary-adrenal axis stress responses in late pregnancy: changes in feed forward and feedback mechanisms. J. Neuroendocrinol. 2000, 12:811-822.
122. Julan L., Guan H., van Beek J.P., Yang K. Peroxisome proliferator-activated receptor delta suppresses 11beta-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells. Endocrinology 2005, 146:1482-1490.
123. Kalabis G.M., Petropoulos S., Gibb W., Matthews S.G. Multidrug resistance phosphoglycoprotein (ABCB1) expression in the guinea pig placenta: developmental changes and regulation by betamethasone. Can. J. Physiol. Pharmacol. 2009, 87:973-978.
124. Karssen A.M., Meijer O.C., van der Sandt I.C., Lucassen P.J., de Lange E.C., de Boer A.G., de Kloet E.R. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001, 142:2686-2694.
125. Kenouch S., Lombes M., Delahaye F., Eugene E., Bonvalet J.P., Farman N. Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase. J. Clin. Endocrinol. Metab. 1994, 79:1334-1341.
126. Kershaw E.E., Morton N.M., Dhillon H., Ramage L., Seckl J.R., Flier J.S. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 2005, 54:1023-1031.
127. Kim J.H., Jittiwat J., Ong W.Y., Farooqui A.A., Jenner A.M. Changes in cholesterol biosynthetic and transport pathways after excitotoxicity. J. Neurochem. 2010, 112:34-41.
128. Kitraki E., Kittas C., Stylianopoulou F. Glucocorticoid receptor gene expression during rat embryogenesis, an in situ hybridization study. Differentiation 1997, 62:21-31.
129. Kliewer S.A., Moore J.T., Wade L., Staudinger J.L., Watson M.A., Jones S.A., McKee D.D., Oliver B.B., Willson T.M., Zetterstrom R.H., Perlmann T., Lehmann J.M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998, 92:73-82.
130. Koenig J.I., Elmer G.I., Shepard P.D., Lee P.R., Mayo C., Joy B., Hercher E., Brady D.L. Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav. Brain Res. 2005, 156:251-261.
131. Korbonits M., Bujalska I., Shimojo M., Nobes J., Jordan S., Grossman A.B., Stewart P.M. Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. J. Clin. Endocrinol. Metab. 2001, 86:2728-2733.
132. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci. Biobehav. Rev. 2001, 25:117-142.
133. Kossintseva I., Wong S., Johnstone E., Guilbert L., Olson D.M., Mitchell B.F. Proinflammatory cytokines inhibit human placental 11beta-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E282-E288.
134. Kotelevtsev Y., Brown R.W., Fleming S., Kenyon C., Edwards C.R., Seckl J.R., Mullins J.J. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J. Clin. Invest. 1999, 103:683-689.
135. Kotelevtsev Y., Holmes M.C., Burchell A., Houston P.M., Schmoll D., Jamieson P., Best R., Brown R., Edwards C.R., Seckl J.R., Mullins J.J. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. USA 1997, 94:14924-14929.
136. Lai M., Horsburgh K., Bae S.E., Carter R.N., Stenvers D.J., Fowler J.H., Yau J.L., Gomez-Sanchez C.E., Holmes M.C., Kenyon C.J., Seckl J.R., Macleod M.R. Forebrain mineralocorticoid receptor overexpression enhances memory reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur. J. Neurosci. 2007, 25:1832-1842.
137. Lakshmi V., Monder C. Evidence for independent 11-oxidase and 11-reductase activities of 11 beta-hydroxysteroid dehydrogenase: enzyme latency, phase transitions, and lipid requirements. Endocrinology 1985, 116:552-560.
138. Lakshmi V., Monder C. Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex. Endocrinology 1988, 123:2390-2398.
139. Lakshmi V., Sakai R.R., McEwen B.S., Monder C. Regional distribution of 11 beta-hydroxysteroid dehydrogenase in rat brain. Endocrinology 1991, 128:1741-1748.
140. Landfield P.W., Baskin R.K., Pitler T.A. Brain aging correlates: retardation by hormonal-pharmacological treatments. Science 1981, 214:581-584.
141. Langdown M.L., Sugden M.C. Enhanced placental GLUT 1 and GLUT 3 expression in dexamethasone-induced fetal growth retardation. Mol. Cell Endocrinol. 2001, 185:109-117.
142. Langley-Evans S.C., Philips G., Benediktsson R., Gardner D., Edwards C.R.W., Jackson A.A., Seckl J.R. Maternal dietary protein restriction, placental glucocorticoid metabolism and the programming of hypertension. Placenta 1996, 17:169-172.
143. Lavery G.G., Walker E.A., Draper N., Jeyasuria P., Marcos J., Shackleton C.H., Parker K.L., White P.C., Stewart P.M. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J. Biol. Chem. 2006, 281:6546-6551.
144. Lavery G.G., Walker E.A., Tiganescu A., Ride J.P., Shackleton C.H., Tomlinson J.W., Connell J.M., Ray D.W., Biason-Lauber A., Malunowicz E.M., Arlt W., Stewart P.M. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. J. Clin. Endocrinol. Metab. 2008, 93:3827-3832.
145. Lax E.R., Ghraf R., Schriefers H. The hormonal regulation of hepatic microsomal 11beta-hydroxysteroid dehydrogenase activity in the rat. Acta Endocrinol. (Copenh) 1978, 89:352-358.
146. Lax E.R., Ghraf R., Schriefers H., Voigt K.H. The involvement of the thyroid and adrenal in the regulation of enzyme activities of hepatic and renal steroid metabolism in the rat. Hoppe Seylers Z Physiol. Chem. 1979, 360:137-143.
147. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., Koenig J.I. Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin. Brain Res. 2007, 1156:152-167.
148. Lesage J., Blondeau B., Grino M., Breant B., Dupouy J.P. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology 2001, 142:1692-1702.
149. Levitt N.S., Lindsay R.S., Holmes M.C., Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 1996, 64:412-418.
150. Lindsay R.S., Lindsay R.M., Edwards C.R., Seckl J.R. Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 1996, 27:1200-1204.
151. Livingstone D.E., Jones G.C., Smith K., Jamieson P.M., Andrew R., Kenyon C.J., Walker B.R. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000, 141:560-563.
152. Llorente R., Gallardo M.L., Berzal A.L., Prada C., Garcia-Segura L.M., Viveros M.P. Early maternal deprivation in rats induces gender-dependent effects on developing hippocampal and cerebellar cells. Int. J. Dev. Neurosci. 2009, 27:233-241.
153. Low S.C., Assaad S.N., Rajan V., Chapman K.E., Edwards C.R., Seckl J.R. Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J. Endocrinol. 1993, 139:27-35.
154. Low S.C., Chapman K.E., Edwards C.R., Wells T., Robinson I.C., Seckl J.R. Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J. Endocrinol. 1994, 143:541-548.
155. Low S.C., Moisan M.P., Noble J.M., Edwards C.R., Seckl J.R. Glucocorticoids regulate hippocampal 11 beta-hydroxysteroid dehydrogenase activity and gene expression in vivo in the rat. J. Neuroendocrinol. 1994, 6:285-290.
156. Maccari S., Morley-Fletcher S. Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations. Psychoneuroendocrinology 2007, 32(Suppl 1):S10-S15.
157. Macleod M.R., Johansson I.M., Soderstrom I., Lai M., Gido G., Wieloch T., Seckl J.R., Olsson T. Mineralocorticoid receptor expression and increased survival following neuronal injury. Eur. J. Neurosci. 2003, 17:1549-1555.
158. MacLullich A.M., Deary I.J., Starr J.M., Walker B.R., Secki J.R. Glycosylated hemoglobin levels in healthy elderly nondiabetic men are negatively associated with verbal memory. J. Am. Geriatr. Soc. 2004, 52:848-849.
159. Maclullich A.M., Ferguson K.J., Reid L.M., Deary I.J., Starr J.M., Wardlaw J.M., Walker B.R., Andrew R., Seckl J.R. 11beta-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline. Neurobiol. Aging 2010.
160. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995, 69:89-98.
161. Mandyam C.D., Crawford E.F., Eisch A.J., Rivier C.L., Richardson H.N. Stress experienced in utero reduces sexual dichotomies in neurogenesis, microenvironment, and cell death in the adult rat hippocampus. Dev. Neurobiol. 2008, 68:575-589.
162. Mark P.J., Waddell B.J. P-glycoprotein restricts access of cortisol and dexamethasone to the glucocorticoid receptor in placental BeWo cells. Endocrinology 2006, 147:5147-5152.
163. Masuzaki H., Flier J.S. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) - a promising drug target for the treatment of metabolic syndrome. Curr. Drug Targets Immun. Endocr. Metabol. Disord. 2003, 3:255-262.
164. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
165. McEwan I.J., Wright A.P., Gustafsson J.A. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays 1997, 19:153-160.
166. Meaney M.J., Aitken D.H., van Berkel C., Bhatnagar S., Sapolsky R.M. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988, 239:766-768.
167. Meaney M.J., Diorio J., Francis D., Widdowson J., LaPlante P., Caldji C., Sharma S., Seckl J.R., Plotsky P.M. Early environmental regulation of forebrain glucocorticoid receptor gene expression: Implications for adrenocortical responses to stress. Dev. Neurosci. 1996, 18:49-72.
168. Meaney M.J., O'Donnell D., Rowe W., Tannenbaum B., Steverman A., Walker M., Nair N.P., Lupien S. Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp. Gerontol. 1995, 30:229-251.
169. Meijer O.C., de Lange E.C., Breimer D.D., de Boer A.G., Workel J.O., de Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998, 139:1789-1793.
170. Melis D., Parenti G., Della Casa R., Sibilio M., Romano A., Di Salle F., Elefante R., Mansi G., Santoro L., Perretti A., Paludetto R., Sequino L., Andria G. Brain damage in glycogen storage disease type I. J. Pediatr. 2004, 144:637-642.
171. Meyer J.S. Early adrenalectomy stimulates subsequent growth and development of the rat brain. Exp. Neurol. 1983, 82:432-446.
172. Meyer J.S. Biochemical effects of corticosteroids on neural tissues. Physiol. Rev. 1985, 65:946-1020.
173. Michailidou Z., Jensen M.D., Dumesic D.A., Chapman K.E., Seckl J.R., Walker B.R., Morton N.M. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring) 2007, 15:1155-1163.
174. Mirescu C., Peters J.D., Gould E. Early life experience alters response of adult neurogenesis to stress. Nat. Neurosci. 2004, 7:841-846.
175. Miyabo S., Kishida S., Hisada T. Metabolism and conjugation of cortisol by various dog tissues in vitro. J. Steroid. Biochem. 1973, 4:567-576.
176. Moguilewsky M., Raynaud J.P. Evidence for a specific mineralocorticoid receptor in rat pituitary and brain. J. Steroid. Biochem. 1980, 12:309-314.
177. Moisan M.P., Edwards C.R., Seckl J.R. Differential promoter usage by the rat 11 beta-hydroxysteroid dehydrogenase gene. Mol. Endocrinol. 1992, 6:1082-1087.
178. Moisan M.P., Edwards C.R., Seckl J.R. Ontogeny of 11 beta-hydroxysteroid dehydrogenase in rat brain and kidney. Endocrinology 1992, 130:400-404.
179. Moisan M.P., Seckl J.R., Brett L.P., Monder C., Agarwal A.K., White P.C., Edwards C.R. 11Beta-Hydroxysteroid dehydrogenase messenger ribonucleic acid expression, bioactivity and immunoreactivity in rat cerebellum. J. Neuroendocrinol. 1990, 2:853-858.
180. Moisan M.P., Seckl J.R., Edwards C.R. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology 1990, 127:1450-1455.
181. Monder C. Corticosteroids, receptors, and the organ-specific functions of 11 beta-hydroxysteroid dehydrogenase. Faseb J. 1991, 5:3047-3054.
182. Monder C., Shackleton C.H., Bradlow H.L., New M.I., Stoner E., Iohan F., Lakshmi V. The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism. J. Clin. Endocrinol. Metab. 1986, 63:550-557.
183. Montano M.M., Wang M.H., Even M.D., vom Saal F.S. Serum corticosterone in fetal mice: sex differences, circadian changes, and effect of maternal stress. Physiol. Behav. 1991, 50:323-329.
184. Morton N.M., Holmes M.C., Fievet C., Staels B., Tailleux A., Mullins J.J., Seckl J.R. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. 2001, 276:41293-41300.
185. Morton N.M., Paterson J.M., Masuzaki H., Holmes M.C., Staels B., Fievet C., Walker B.R., Flier J.S., Mullins J.J., Seckl J.R. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004, 53:931-938.
186. Morton N.M., Seckl J.R. 11beta-hydroxysteroid dehydrogenase type 1 and obesity. Front Horm. Res. 2008, 36:146-164.
187. Moss T.J., Doherty D.A., Nitsos I., Sloboda D.M., Harding R., Newnham J.P. Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am. J. Obstet. Gynecol. 2005, 192:146-152.
188. Mune T., Rogerson F.M., Nikkila H., Agarwal A.K., White P.C. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat. Genet. 1995, 10:394-399.
189. Muneoka K., Mikuni M., Ogawa T., Kitera K., Kamei K., Takigawa M., Takahashi K. Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. Am. J. Physiol. 1997, 273:R1669-R1675.
190. Murphy V.E., Zakar T., Smith R., Giles W.B., Gibson P.G., Clifton V.L. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J. Clin. Endocrinol. Metab. 2002, 87:1660-1668.
191. Nagano M., Ozawa H., Suzuki H. Prenatal dexamethasone exposure affects anxiety-like behaviour and neuroendocrine systems in an age-dependent manner. Neurosci. Res. 2008, 60:364-371.
192. Naray-Fejes-Toth A., Fejes-Toth G. Novel mouse strain with Cre recombinase in 11beta-hydroxysteroid dehydrogenase-2-expressing cells. Am. J. Physiol. Renal. Physiol. 2007, 292:F486-F494.
193. G. Naredo-Gonzalez, M.A. Jansen, G.D. Merrifield, O.B. Sutcliffe, M.K. Hansen, R. Andrew, B.R. Walker, Non-invasive in-vivo monitoring of 11ß-HSD1 activity using 19F-magnetic resonance imaging. The Endocrine Society - 92nd Annual Meeting P3-32, 2010.
194. Nashev L.G., Chandsawangbhuwana C., Balazs Z., Atanasov A.G., Dick B., Frey F.J., Baker M.E., Odermatt A. Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids. PLoS One 2007, 2:e561.
195. Newnham J.P., Jobe A.H. Should we be prescribing repeated courses of antenatal corticosteroids?. Semin. Fetal Neonatal Med. 2009, 14:157-163.
196. Nyirenda M.J., Carter R., Tang J.I., de Vries A., Schlumbohm C., Hillier S.G., Streit F., Oellerich M., Armstrong V.W., Fuchs E., Seckl J.R. Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes 2009, 58:2873-2879.
197. Nyirenda M.J., Dean S., Lyons V., Chapman K.E., Seckl J.R. Prenatal programming of hepatocyte nuclear factor 4alpha in the rat: A key mechanism in the 'foetal origins of hyperglycaemia'?. Diabetologia 2006, 49:1412-1420.
198. Nyirenda M.J., Lindsay R.S., Kenyon C.J., Burchell A., Seckl J.R. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest. 1998, 101:2174-2181.
199. O'Connor T.G., Ben-Shlomo Y., Heron J., Golding J., Adams D., Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol. Psychiat. 2005, 58:211-217.
200. O'Regan D., Kenyon C.J., Seckl J.R., Holmes M.C. Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E863-E870.
201. Odermatt A., Atanasov A.G., Balazs Z., Schweizer R.A., Nashev L.G., Schuster D., Langer T. Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1. Mol. Cell Endocrinol. 2006, 248:15-23.
202. Pardon M.C., Rattray I. What do we know about the long-term consequences of stress on ageing and the progression of age-related neurodegenerative disorders?. Neurosci. Biobehav. Rev. 2008.
203. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab. 1996, 81:1460-1464.
204. Pasquarette M.M., Stewart P.M., Ricketts M.L., Imaishi K., Mason J.I. Regulation of 11 beta-hydroxysteroid dehydrogenase type 2 activity and mRNA in human choriocarcinoma cells. J. Mol. Endocrinol. 1996, 16:269-275.
205. Paterson J.M., Holmes M.C., Kenyon C.J., Carter R., Mullins J.J., Seckl J.R. Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice. Endocrinology 2007, 148:961-966.
206. Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B., Seckl J.R., Mullins J.J. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc. Natl. Acad. Sci. USA 2004, 101:7088-7093.
207. Pepe G.J., Burch M.G., Albrecht E.D. Estrogen regulates 11 beta-hydroxysteroid dehydrogenase-1 and -2 localization in placental syncytiotrophoblast in the second half of primate pregnancy. Endocrinology 2001, 142:4496-4503.
208. Perlman W.R., Webster M.J., Kleinman J.E., Weickert C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol. Psychiat. 2004, 56:844-852.
209. Peterson N.A., Chaikoff I.L., Jones C. The in vitro conversion of cortisol to cortisone by subcellular brain fractions of young and adult rats. J. Neurochem. 1965, 12:273-278.
210. Peterson R.E., Imperato-McGinley J., Gautier T., Sturla E. Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency. Am. J. Med. 1977, 62:170-191.
211. Poletto R., Steibel J.P., Siegford J.M., Zanella A.J. Effects of early weaning and social isolation on the expression of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 1 and 2 mRNAs in the frontal cortex and hippocampus of piglets. Brain Res. 2006, 1067:36-42.
212. Raikkonen K., Pesonen A.K., Heinonen K., Lahti J., Komsi N., Eriksson J.G., Seckl J.R., Jarvenpaa A.L., Strandberg T.E. Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children. Am. J. Epidemiol. 2009, 170:1137-1146.
213. Raikkonen K., Seckl J.R., Heinonen K., Pyhala R., Feldt K., Jones A., Pesonen A.K., Phillips D.I., Lahti J., Jarvenpaa A.L., Eriksson J.G., Matthews K.A., Strandberg T.E., Kajantie E. Maternal prenatal licorice consumption alters hypothalamic-pituitary-adrenocortical axis function in children. Psychoneuroendocrinology 2010.
214. Rajan V., Chapman K.E., Lyons V., Jamieson P., Mullins J.J., Edwards C.R., Seckl J.R. Cloning, sequencing and tissue-distribution of mouse 11 beta-hydroxysteroid dehydrogenase-1 cDNA. J. Steroid Biochem. Mol. Biol. 1995, 52:141-147.
215. Rajan V., Edwards C.R., Seckl J.R. 11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J. Neurosci. 1996, 16:65-70.
216. Rask E., Olsson T., Soderberg S., Andrew R., Livingstone D.E., Johnson O., Walker B.R. Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab. 2001, 86:1418-1421.
217. Raubenheimer P.J., Young E.A., Andrew R., Seckl J.R. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback. Clin. Endocrinol. (Oxf) 2006, 65:22-26.
218. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
219. Reul J.M., de Kloet E.R., van Sluijs F.J., Rijnberk A., Rothuizen J. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology 1990, 127:907-915.
220. Reul J.M., Gesing A., Droste S., Stec I.S., Weber A., Bachmann C., Bilang-Bleuel A., Holsboer F., Linthorst A.C. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur. J. Pharmacol. 2000, 405:235-249.
221. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hortnagl H., Flor H., Henn F.A., Schutz G., Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 2005, 25:6243-6250.
222. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev. 2006, 3:CD004454.
223. Robinzon B., Michael K.K., Ripp S.L., Winters S.J., Prough R.A. Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases?. Arch. Biochem. Biophys. 2003, 412:251-258.
224. Robson A.C., Leckie C.M., Seckl J.R., Holmes M.C. 11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Brain Res. Mol. Brain Res. 1998, 61:1-10.
225. Roland B.L., Funder J.W. Localization of 11beta-hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies. Endocrinology 1996, 137:1123-1128.
226. Roland B.L., Krozowski Z.S., Funder J.W. Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Mol. Cell Endocrinol. 1995, 111:R1-R7.
227. Roland B.L., Li K.X., Funder J.W. Hybridization histochemical localization of 11 beta-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology 1995, 136:4697-4700.
228. Rosenstock J., Banarer S., Fonseca V.A., Inzucchi S.E., Sun W., Yao W., Hollis G., Flores R., Levy R., Williams W.V., Seckl J.R., Huber R. The 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients with Type 2 Diabetes Inadequately Controlled By Metformin Monotherapy. Diabetes Care 2010.
229. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 1990, 11:80-91.
230. Rowland N.E., Fregly M.J. Sodium appetite: species and strain differences and role of renin-angiotensin-aldosterone system. Appetite 1988, 11:143-178.
231. Rusvai E., Naray-Fejes-Toth A. A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells. J. Biol. Chem. 1993, 268:10717-10720.
232. Sai S., Esteves C.L., Kelly V., Michailidou Z., Anderson K., Coll A.P., Nakagawa Y., Ohzeki T., Seckl J.R., Chapman K.E. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta. Mol. Endocrinol. 2008, 22:2049-2060.
233. Sandeep T.C., Yau J.L., MacLullich A.M., Noble J., Deary I.J., Walker B.R., Seckl J.R. 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc. Natl. Acad. Sci. USA 2004, 101:6734-6739.
234. Sapolsky R.M. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J. Neurosci. 1985, 5:1228-1232.
235. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci. 1985, 5:1222-1227.
236. Sarkar S., Tsai S.W., Nguyen T.T., Plevyak M., Padbury J.F., Rubin L.P. Inhibition of placental 11beta-hydroxysteroid dehydrogenase type 2 by catecholamines via alpha-adrenergic signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R1966-R1974.
237. Sasano H., Uzuki M., Sawai T., Nagura H., Matsunaga G., Kashimoto O., Harada N. Aromatase in human bone tissue. J. Bone Miner. Res. 1997, 12:1416-1423.
238. Schweizer R.A., Zurcher M., Balazs Z., Dick B., Odermatt A. Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. J. Biol. Chem. 2004, 279:18415-18424.
239. Seckl J.R. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr. Opin. Pharmacol. 2004, 4:597-602.
240. Seckl J.R. Glucocorticoids, developmental 'programming' and the risk of affective dysfunction. Prog. Brain Res. 2008, 167:17-34.
241. Seckl J.R., Dow R.C., Low S.C., Edwards C.R., Fink G. The 11 beta-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats. J. Endocrinol. 1993, 136:471-477.
242. Seckl J.R., Holmes M.C. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:479-488.
243. Sequeira S.M., Geerling J.C., Loewy A.D. Local inputs to aldosterone-sensitive neurons of the nucleus tractus solitarius. Neuroscience 2006, 141:1995-2005.
244. Shackleton C.H., Honour J.W., Dillon M.J., Chantler C., Jones R.W. Hypertension in a four-year-old child: gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids. J. Clin. Endocrinol. Metab. 1980, 50:702-786.
245. Shackleton C.H., Rodriguez J., Arteaga E., Lopez J.M., Winter J.S. Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. Clin. Endocrinol. (Oxf) 1985, 22:701-712.
246. Sharma A., Guan H., Yang K. The p38 mitogen-activated protein kinase regulates 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) expression in human trophoblast cells through modulation of 11beta-HSD2 messenger ribonucleic acid stability. Endocrinology 2009, 150:4278-4286.
247. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 1996, 93:3908-3913.
248. Shih D.Q., Bussen M., Sehayek E., Ananthanarayanan M., Shneider B.L., Suchy F.J., Shefer S., Bollileni J.S., Gonzalez F.J., Breslow J.L., Stoffel M. Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet. 2001, 27:375-382.
249. Shimojo M., Whorwood C.B., Stewart P.M. 11 beta-Hydroxysteroid dehydrogenase in the rat adrenal. J. Mol. Endocrinol. 1996, 17:121-130.
250. Shin J.W., Geerling J.C., Loewy A.D. Vagal innervation of the aldosterone-sensitive HSD2 neurons in the NTS. Brain Res. 2009, 1249:135-147.
251. Shoener J.A., Baig R., Page K.C. Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1366-R1373.
252. Sholiton L.J., Werk E.E., MacGee J. Metabolism of cortisol-4-C-14 and cortisone-4-C-14 by rat brain homogenates. Metabolism 1965, 14:1122-1127.
253. Sloboda D.M., Moss T.J., Gurrin L.C., Newnham J.P., Challis J.R. The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary-adrenal function. J. Endocrinol. 2002, 172:71-81.
254. Sloboda D.M., Moss T.J., Li S., Matthews S.G., Challis J.R., Newnham J.P. Expression of glucocorticoid receptor, mineralocorticoid receptor, and 11beta-hydroxysteroid dehydrogenase 1 and 2 in the fetal and postnatal ovine hippocampus: ontogeny and effects of prenatal glucocorticoid exposure. J. Endocrinol. 2008, 197:213-220.
255. Smith J.T., Waddell B.J. Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology 2000, 141:2422-2428.
256. K. Sooy, S.P. Webster, J. Noble, M. Binnie, B.R. Walker, J.R. Seckl, J.L. Yau, Partial deficiency or short-term inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice, J. Neurosci. 30 13867-72.
257. Speirs H.J., Seckl J.R., Brown R.W. Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development. J. Endocrinol. 2004, 181:105-116.
258. Stavreva D.A., Wiench M., John S., Conway-Campbell B.L., McKenna M.A., Pooley J.R., Johnson T.A., Voss T.C., Lightman S.L., Hager G.L. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat. Cell Biol. 2009, 11:1093-1102.
259. Stein M.B., Koverola C., Hanna C., Torchia M.G., McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol. Med. 1997, 27:951-959.
260. Stewart P.M., Corrie J.E., Shackleton C.H., Edwards C.R. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J. Clin. Invest. 1988, 82:340-349.
261. Stewart P.M., Murry B.A., Mason J.I. Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab. 1994, 78:1529-1532.
262. Stewart P.M., Rogerson F.M., Mason J.I. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J. Clin. Endocrinol. Metab. 1995, 80:885-890.
263. Stewart P.M., Tomlinson J.W. Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?. Diabetes 2009, 58:14-15.
264. Stewart P.M., Wallace A.M., Atherden S.M., Shearing C.H., Edwards C.R. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man. Clin. Sci. (Lond) 1990, 78:49-54.
265. Stewart P.M., Wallace A.M., Valentino R., Burt D., Shackleton C.H., Edwards C.R. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987, 2:821-824.
266. Stewart P.M., Whorwood C.B., Mason J.I. Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life. J. Steroid Biochem. Mol. Biol. 1995, 55:465-471.
267. Strachan M.W., Deary I.J., Ewing F.M., Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diab. Care 1997, 20:438-445.
268. Stulnig T.M., Oppermann U., Steffensen K.R., Schuster G.U., Gustafsson J.A. Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. Diabetes 2002, 51:2426-2433.
269. Sun K., He P., Yang K. Intracrine induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast. Biol. Reprod. 2002, 67:1450-1455.
270. Sun K., Yang K., Challis J.R. Differential regulation of 11 beta-hydroxysteroid dehydrogenase type 1 and 2 by nitric oxide in cultured human placental trophoblast and chorionic cell preparation. Endocrinology 1997, 138:4912-4920.
271. Sun K., Yang K., Challis J.R. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5'-monophosphate pathway in cultured human placental and chorionic trophoblasts. Biol. Reprod. 1998, 58:1379-1384.
272. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Age. Res. Rev. 2005, 4:141-194.
273. Thompson A., Han V.K., Yang K. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development. J. Steroid Biochem. Mol. Biol. 2004, 88:367-375.
274. Torpy D.J., Ho J.T. Value of free cortisol measurement in systemic infection. Horm. Metab. Res. 2007, 39:439-444.
275. Tremblay J., Hardy D.B., Pereira L.E., Yang K. Retinoic acid stimulates the expression of 11beta-hydroxysteroid dehydrogenase type 2 in human choriocarcinoma JEG-3 cells. Biol. Reprod. 1999, 60:541-545.
276. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., Schütz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 1999, 23:99-103.
277. Ulick S., Levine L.S., Gunczler P., Zanconato G., Ramirez L.C., Rauh W., Rosler A., Bradlow H.L., New M.I. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocrinol. Metab. 1979, 49:757-764.
278. Uno H., Eisele S., Sakai A., Shelton S., Baker E., DeJesus O., Holden J. Neurotoxicity of glucocorticoids in the primate brain. Horm. Behav. 1994, 28:336-348.
279. Uno H., Lohmiller L., Thieme C., Kemnitz J.W., Engle M.J., Roecker E.B., Farrell P.M. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res. Dev. Brain Res. 1990, 53:157-167.
280. van Beek J.P., Guan H., Julan L., Yang K. Glucocorticoids stimulate the expression of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human placental trophoblast cells. J. Clin. Endocrinol. Metab. 2004, 89:5614-5621.
281. Van den Berg D.T., de Jong W., de Kloet E.R. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming. Am. J. Physiol. 1994, 267:E921-E926.
282. Van den Bergh B.R., Van Calster B., Smits T., Van Huffel S., Lagae L. Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 2008, 33:536-545.
283. Velazquez P.N., Romano M.C. Corticosterone therapy during gestation: effects on the development of rat cerebellum. Int. J. Dev. Neurosci. 1987, 5:189-194.
284. Veniant M.M., Hale C., Komorowski R., Chen M.M., St Jean D.J., Fotsch C., Wang M. Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice. Diab. Obes. Metab. 2009, 11:109-117.
285. Virgin C.E., Ha T.P., Packan D.R., Tombaugh G.C., Yang S.H., Horner H.C., Sapolsky R.M. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J. Neurochem. 1991, 57:1422-1428.
286. Voice M.W., Seckl J.R., Edwards C.R., Chapman K.E. 11 beta-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism. Biochem. J. 1996, 317(Pt 2):621-625.
287. Waddell B.J., Benediktsson R., Brown R.W., Seckl J.R. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action. Endocrinology 1998, 139:1517-1523.
288. Walker B.R., Andrew R. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann. NY Acad. Sci. 2006, 1083:165-184.
289. Walker B.R., Connacher A.A., Lindsay R.M., Webb D.J., Edwards C.R. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J. Clin. Endocrinol. Metab. 1995, 80:3155-3159.
290. Walker B.R., Williams B.C., Edwards C.R. Regulation of 11 beta-hydroxysteroid dehydrogenase activity by the hypothalamic-pituitary-adrenal axis in the rat. J. Endocrinol. 1994, 141:467-472.
291. Walker E.A., Ahmed A., Lavery G.G., Tomlinson J.W., Kim S.Y., Cooper M.S., Ride J.P., Hughes B.A., Shackleton C.H., McKiernan P., Elias E., Chou J.Y., Stewart P.M. 11beta-Hydroxysteroid dehydrogenase Type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and hypothalamo-pituitary-adrenal axis function. J. Biol. Chem. 2007, 282:27030-27036.
292. Walsh P.C., Madden J.D., Harrod M.J., Goldstein J.L., MacDonald P.C., Wilson J.D. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. New Engl. J. Med. 1974, 291:944-949.
293. Wamil M., Andrew R., Chapman K.E., Street J., Morton N.M., Seckl J.R. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type. Endocrinology 2008, 149:5909-5918.
294. Wan S., Hao R., Sun K. Repeated maternal dexamethasone treatments in late gestation increases 11beta-hydroxysteroid dehydrogenase type 1 expression in the hippocampus of the newborn rat. Neurosci. Lett. 2005, 382:96-101.
295. Watson S., Thompson J.M., Ritchie J.C., Nicol Ferrier I., Young A.H. Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function. Bipolar. Disord. 2006, 8:85-90.
296. Weaver I.C.G., Cervoni N., Champagne F., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
297. Webster M.J., Knable M.B., O'Grady J., Orthmann J., Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiat. 2002, 7:985-994. 924.
298. Welberg L.A., Seckl J.R., Holmes M.C. Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring. Eur. J. Neurosci. 2000, 12:1047-1054.
299. Welberg L.A., Seckl J.R., Holmes M.C. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 2001, 104:71-79.
300. Whorwood C.B., Donovan S.J., Wood P.J., Phillips D.I. Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance?. J. Clin. Endocrinol. Metab. 2001, 86:2296-2308.
301. Whorwood C.B., Ricketts M.L., Stewart P.M. Epithelial cell localization of type 2 11 beta-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology 1994, 135:2533-2541.
302. Wilber A.A., Wellman C.L. Neonatal maternal separation alters the development of glucocorticoid receptor expression in the interpositus nucleus of the cerebellum. Int. J. Dev. Neurosci. 2009, 27:649-654.
303. Williams L.J., Lyons V., MacLeod I., Rajan V., Darlington G.J., Poli V., Seckl J.R., Chapman K.E. C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. J. Biol. Chem. 2000, 275:30232-30239.
304. Wolkowitz O.M., Burke H., Epel E.S., Reus V.I. Glucocorticoids. Mood, memory, and mechanisms. Ann. NY Acad. Sci. 2009, 1179:19-40.
305. Woods L.L., Weeks D.A. Prenatal programming of adult blood pressure: role of maternal corticosteroids. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R955-R962.
306. Wyrwoll C.S., Mark P.J., Mori T.A., Puddey I.B., Waddell B.J. Prevention of programmed hyperleptinemia and hypertension by postnatal dietary omega-3 fatty acids. Endocrinology 2006, 147:599-606.
307. Wyrwoll C.S., Mark P.J., Waddell B.J. Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system. Hypertension 2007, 50:579-584.
308. Wyrwoll C.S., Seckl J.R., Holmes M.C. Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology 2009, 150:1287-1293.
309. Yang K., Berdusco E.T., Challis J.R. Opposite effects of glucocorticoid on hepatic 11 beta-hydroxysteroid dehydrogenase mRNA and activity in fetal and adult sheep. J. Endocrinol. 1994, 143:121-126.
310. Yang K., Julan L., Rubio F., Sharma A., Guan H. Cadmium reduces 11 beta-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E135-E142.
311. Yang Z., Zhu P., Guo C., Zhu X., Sun K. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in human fetal lung and regulation of its expression by interleukin-1beta and cortisol. J. Clin. Endocrinol. Metab. 2009, 94:306-313.
312. Yau J.L., McNair K.M., Noble J., Brownstein D., Hibberd C., Morton N., Mullins J.J., Morris R.G., Cobb S., Seckl J.R. Enhanced hippocampal long-term potentiation and spatial learning in aged 11beta-hydroxysteroid dehydrogenase type 1 knock-out mice. J. Neurosci. 2007, 27:10487-10496.
313. Yau J.L., Noble J., Graham M., Seckl J.R. Central administration of a cytochrome P450-7B product 7 alpha-hydroxypregnenolone improves spatial memory retention in cognitively impaired aged rats. J. Neurosci. 2006, 26:11034-11040.
314. Yau J.L., Noble J., Hibberd C., Rowe W.B., Meaney M.J., Morris R.G., Seckl J.R. Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J. Neurosci. 2002, 22:1436-1442.
315. Yau J.L., Noble J., Kenyon C.J., Hibberd C., Kotelevtsev Y., Mullins J.J., Seckl J.R. Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc. Natl. Acad. Sci. USA 2001, 98:4716-4721.
316. Ye P., Kenyon C.J., Mackenzie S.M., Nichol K., Seckl J.R., Fraser R., Connell J.M., Davies E. Effects of ACTH, dexamethasone, and adrenalectomy on 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system. J. Endocrinol. 2008, 196:305-311.
317. Yehuda R. Status of glucocorticoid alterations in post-traumatic stress disorder. Ann. NY Acad. Sci. 2009, 1179:56-69.
318. Yehuda R., Engel S.M., Brand S.R., Seckl J., Marcus S.M., Berkowitz G.S. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the world trade center attacks during pregnancy. J. Clin. Endocrinol. Metab. 2005, 90:4115-4118.
319. Yehuda R., Teicher M.H., Seckl J.R., Grossman R.A., Morris A., Bierer L.M. Parental posttraumatic stress disorder as a vulnerability factor for low cortisol trait in offspring of holocaust survivors. Arch. Gen. Psychiat. 2007, 64:1040-1048.
320. Young A.H. Antiglucocoticoid treatments for depression. Aust. N Z J. Psychiat. 2006, 40:402-405.
321. Yu L., Romero D.G., Gomez-Sanchez C.E., Gomez-Sanchez E.P. Steroidogenic enzyme gene expression in the human brain. Mol. Cell Endocrinol. 2002, 190:9-17.
322. Zhang Z.H., Kang Y.M., Yu Y., Wei S.G., Schmidt T.J., Johnson A.K., Felder R.B. 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension 2006, 48:127-133.
323. Zhu Y., Olson S.H., Graham D., Patel G., Hermanowski-Vosatka A., Mundt S., Shah K., Springer M., Thieringer R., Wright S., Xiao J., Zokian H., Dragovic J., Balkovec J.M. Phenylcyclobutyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I. Bioorg. Med. Chem. Lett. 2008, 18:3412-3416.
324. Zhu Y., Olson S.H., Hermanowski-Vosatka A., Mundt S., Shah K., Springer M., Thieringer R., Wright S., Xiao J., Zokian H., Balkovec J.M. 4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I. Bioorg. Med. Chem. Lett. 2008, 18:3405-3411.